Reported Standalone quarterly numbers for Bliss GVS Pharma are:Net Sales at Rs 163.82 crore in March 2024 up 14.22% from Rs. 143.42 crore in March 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 11.46 crore in March 2024 down 287.68% from Rs. 6.11 crore in March 2023.
EBITDA stands at Rs. 33.61 crore in March 2024 up 93.27% from Rs. 17.39 crore in March 2023.
Bliss GVS shares closed at 129.40 on May 02, 2024 (NSE) and has given 33.95% returns over the last 6 months and 68.27% over the last 12 months.
| Bliss GVS Pharma | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'24 | Dec'23 | Mar'23 | | Net Sales/Income from operations | 163.82 | 161.33 | 143.42 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 163.82 | 161.33 | 143.42 | | EXPENDITURE | | Consumption of Raw Materials | 78.50 | 80.60 | 66.87 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 0.87 | 5.26 | 12.10 | | Power & Fuel | -- | -- | -- | | Employees Cost | 20.88 | 20.97 | 18.87 | | Depreciation | 6.23 | 6.25 | 3.97 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 38.41 | 25.85 | 34.67 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 18.92 | 22.41 | 6.94 | | Other Income | 8.46 | 7.90 | 6.48 | | P/L Before Int., Excpt. Items & Tax | 27.38 | 30.31 | 13.42 | | Interest | 1.53 | 1.79 | 4.97 | | P/L Before Exceptional Items & Tax | 25.85 | 28.52 | 8.44 | | Exceptional Items | -41.09 | -- | -- | | P/L Before Tax | -15.23 | 28.52 | 8.44 | | Tax | -3.77 | 7.80 | 2.34 | | P/L After Tax from Ordinary Activities | -11.46 | 20.72 | 6.11 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -11.46 | 20.72 | 6.11 | | Equity Share Capital | 10.47 | 10.47 | 10.42 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -1.11 | 1.99 | 0.60 | | Diluted EPS | -1.08 | 1.95 | 0.59 | | EPS After Extra Ordinary | | Basic EPS | -1.11 | 1.99 | 0.60 | | Diluted EPS | -1.08 | 1.95 | 0.59 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
